Austar Lifesciences Ltd Shs Reg S AULSF
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.02–0.02
- Bid/Ask
- $0.00 / $1.30
- Shares Outstanding
- 512.58M
- Market Cap
- $10.25M
- Volume/Avg
- 2,000 / 2,000
Key Statistics
- Price/Earnings (Normalized)
- 3.50
- Price/Sales
- 0.04
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,490
- Website
- https://www.austar.com.hk
Valuation
Metric | AULSF |
|---|---|
Price/Earnings (Normalized) | 3.50 |
Price/Book Value | 0.08 |
Price/Sales | 0.04 |
Price/Cash Flow | 0.42 |
Price/Earnings
AULSF
Financial Strength
Metric | AULSF |
|---|---|
Quick Ratio | 1.02 |
Current Ratio | 1.36 |
Interest Coverage | 4.36 |
Quick Ratio
AULSF
Profitability
Metric | AULSF |
|---|---|
Return on Assets (Normalized) | 0.68% |
Return on Equity (Normalized) | 1.74% |
Return on Invested Capital (Normalized) | 2.03% |
Return on Assets
AULSF
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Cssf$$j | LOCK|h!r%$ | $178B | |||
| Medtronic PLC MDT | LOCK|FBmlYY | LOCK|?$>?? | $128B | |||
| Stryker Corp SYK | LOCK|G#R$kkG | LOCK|%% | $118B | |||
| Boston Scientific Corp BSX | LOCK|kH?^%qw | LOCK|syT# | $61B | |||
| Edwards Lifesciences Corp EW | LOCK|cMY!$D%q | LOCK|hsyc | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|>c%@??d | LOCK|%CH | $36B | |||
| DexCom Inc DXCM | LOCK|L$r#%^# | LOCK|h#dS | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|$W | LOCK|SQS | $28B | |||
| Steris PLC STE | LOCK|#ZgV<f# | LOCK|XpjnD | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|<x<Hf<> | LOCK|tc | $19B |